Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy in pulmonary fibrosis: friend or foe?
Charlotte Hill, Yihua Wang
Genes & Diseases (2021) Vol. 9, Iss. 6, pp. 1594-1607
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Deciphering the fibrotic process: mechanism of chronic radiation skin injury fibrosis
Yiren Wang, Shouying Chen, Shuilan Bao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease
Yerin Kim, Hyung-In Yang, Kyoung Soo Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14509-14509
Open Access | Times Cited: 17
Repositioning of ezetimibe for the treatment of idiopathic pulmonary fibrosis
Chan Ho Lee, Se Hyun Kwak, Jisu Han, et al.
European Respiratory Journal (2024) Vol. 63, Iss. 5, pp. 2300580-2300580
Open Access | Times Cited: 5
Pulmonary fibrosis: pathogenesis and therapeutic strategies
Jianhai Wang, Kuan Li, De Hao, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 4
SIRT2 inhibition attenuates myofibroblast transition through autophagy-mediated ciliogenesis in renal epithelial cells
Juyoung Son, Jaejung Park, Joo‐Won Jeong, et al.
The International Journal of Biochemistry & Cell Biology (2025), pp. 106754-106754
Open Access
Hesperidin alleviates pulmonary fibrosis by regulating EI24-mediated autophagy
Yan Zhang, Wen Ma, Fang Wan
Future Science OA (2025) Vol. 11, Iss. 1
Open Access
Dysregulated bidirectional epithelial–mesenchymal crosstalk: A core determinant of lung fibrosis progression
Liudi Yao, Zijian Xu, Donna E. Davies, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 1, pp. 27-33
Open Access | Times Cited: 3
Leveraging integrative toxicogenomic approach towards development of stressor-centric adverse outcome pathway networks for plastic additives
Ajaya Kumar Sahoo, Nikhil Chivukula, Shreyes Rajan Madgaonkar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Genome-wide RNA sequencing of ocular fibroblasts from glaucomatous and normal eyes: Implications for glaucoma management
Anton W. Roodnat, Breedge Callaghan, Chelsey Doyle, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307227-e0307227
Open Access | Times Cited: 3
ACSL1 improves pulmonary fibrosis by reducing mitochondrial damage and activating PINK1/Parkin mediated mitophagy
Qi Lin, Yifan Lin, Xuefeng Liao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Non-coding RNAs: The recently accentuated molecules in the regulation of cell autophagy for ovarian cancer pathogenesis and therapeutic response
Bi Peng, Jing Li, Yuanliang Yan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Leveraging integrative toxicogenomic approach towards development of stressor-centric adverse outcome pathway networks for plastic additives
Ajaya Kumar Sahoo, Nikhil Chivukula, Shreyes Rajan Madgaonkar, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 10, pp. 3299-3321
Open Access | Times Cited: 2
Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease
Yerin Kim, Hyung-In Yang, A. Kim
(2023)
Open Access | Times Cited: 5
Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways
Wenxin Luo, Yilin Gu, Siyu Fu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115762-115762
Closed Access | Times Cited: 4
Pathological mechanisms and novel drug targets in fibrotic interstitial lung disease
Yasuhiko Nishioka, Jun Araya, Yoshiya Tanaka, et al.
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 1
“Alveolar stem cell exhaustion, fibrosis and bronchiolar proliferation” related entities. A narrative review
M. Chilosi, Sara Piciucchi, Claudia Ravaglia, et al.
Pulmonology (2024)
Open Access | Times Cited: 1
Cellular and Molecular Mechanisms of Hypertrophy of Ligamentum Flavum
Prashanta Silwal, Allison M. Nguyen-Thai, Peter G. Alexander, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1277-1277
Open Access | Times Cited: 1
LKB1 depletion-mediated epithelial–mesenchymal transition induces fibroblast activation in lung fibrosis
Zijian Xu, Elizabeth R. Davies, Liudi Yao, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101065-101065
Open Access | Times Cited: 3
Autophagy modulation by irbesartan mitigates the pulmonary fibrotic alterations in bleomycin challenged rats: Comparative study with rapamycin
Hadeer A. Alsayed, Hala M.F. Mohammad, Cherine M. Khalil, et al.
Life Sciences (2022) Vol. 303, pp. 120662-120662
Closed Access | Times Cited: 5
Predicting rheumatoid arthritis-associated interstitial lung disease: filling the void
David Hutchinson
The Lancet Rheumatology (2023) Vol. 5, Iss. 2, pp. e61-e63
Closed Access | Times Cited: 2
Flavoured and nicotine-containing e-liquids impair homeostatic properties of an alveolar-capillary cell model
Amélia-Naomi Sabo, Emma Filaudeau, Sylvia Da Silva, et al.
Food and Chemical Toxicology (2023) Vol. 174, pp. 113650-113650
Open Access | Times Cited: 2
SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts
Τheodoros Karampitsakos, Apostolos Galaris, Ilianna Barbayianni, et al.
Diagnostics (2023) Vol. 13, Iss. 6, pp. 1166-1166
Open Access | Times Cited: 2
Local Lung Fibroblast Autophagy in the Context of Lung Fibrosis Pathogenesis
Basheer Abdullah Marzoog
Current Respiratory Medicine Reviews (2022) Vol. 19, Iss. 1, pp. 6-11
Closed Access | Times Cited: 3
Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGFß/SMAD pathway
S.H.M. Hassan, Sara F. Saadawy, Samaa M. El‐Mahroky, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5953-5974
Open Access
Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice
Xiu‐Lan Chen, Xin Lin, Lihuan Xu, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top